These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics. Kurland AA; Dim BH; Olsson JE Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356 [No Abstract] [Full Text] [Related]
24. Antiparkinsonian agents and depot phenothiazine. Chien CP; Dimascio A; Cole JO Am J Psychiatry; 1974 Jan; 131(1):86-90. PubMed ID: 4808437 [No Abstract] [Full Text] [Related]
26. Letter: Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys. Shintomi K; Yamamura M J Pharm Pharmacol; 1973 Aug; 25(8):666-7. PubMed ID: 4148443 [No Abstract] [Full Text] [Related]
27. [Review of current pharmacotherapy of Parkinsonism. Comprehensive review]. Benesová O Cesk Neurol; 1973 May; 36(3):196-205. PubMed ID: 4574253 [No Abstract] [Full Text] [Related]
28. Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control. Mindham RH Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):395-400. PubMed ID: 9965 [TBL] [Abstract][Full Text] [Related]
29. A double-blind comparison of the efficacy of EX 10-029 and trihexyphenidyl hydrochloride in relieving drug-induced Parkinsonian symptoms. Freeman H; Mehta IS Curr Ther Res Clin Exp; 1972 Aug; 14(8):470-7. PubMed ID: 4629309 [No Abstract] [Full Text] [Related]
31. Troxonium tosylate in drug-induced Parkinsonism: a controlled comparative study. Pecknold JC; Ananth JV; Ban TA; Lehmann HE J Clin Pharmacol New Drugs; 1971; 11(5):367-70. PubMed ID: 4998432 [No Abstract] [Full Text] [Related]
32. Acute pharmacologic tests in cranial dystonia. Giménez-Roldán S; Mateo D; Orbe M; Muñoz-Blanco JL; Hípola D Adv Neurol; 1988; 49():451-66. PubMed ID: 3344636 [No Abstract] [Full Text] [Related]
33. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia. Sovner R; Dimascio A Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992 [No Abstract] [Full Text] [Related]
34. Acute parkinsonism with corresponding lesions in the basal ganglia after heroin abuse. Mätzler W; Nägele T; Gasser T; Krüger R Neurology; 2007 Feb; 68(6):414. PubMed ID: 17283314 [No Abstract] [Full Text] [Related]
35. Combination therapy of extrapyramidal disease with trihexyphenidyl and L-dopa: an electromyographic study with specific reference to tremor. Hökendorf H J Int Med Res; 1979; 7(1):19-28. PubMed ID: 421963 [TBL] [Abstract][Full Text] [Related]
36. Parkinson's disease. Taylor J Aust Nurses J; 1977 Nov; 7(5):27. PubMed ID: 245293 [No Abstract] [Full Text] [Related]
37. The effect of fluphenazine in psychologically normal volunteers: some temporal, performance, and biochemical relationships. Safer DJ; Allen RP Biol Psychiatry; 1971; 3(3):237-49. PubMed ID: 4150158 [No Abstract] [Full Text] [Related]
39. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Merrick EM; Schmitt PP Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529 [No Abstract] [Full Text] [Related]
40. A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. Mindham RH; Lamb P; Bradley R Br J Psychiatry; 1977 Jun; 130():581-5. PubMed ID: 326325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]